Yekaterina Chudnovsky - 28 Jun 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Director, 10%+ Owner
Signature
/s/ Yekaterina Chudnovsky
Issuer symbol
ELTX
Transactions as of
28 Jun 2024
Net transactions value
+$7,984,000
Form type
4
Filing time
02 Jul 2024, 16:30:42 UTC
Previous filing
21 Jun 2024
Next filing
14 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Common Warrants Purchase $0 +1,600,000 $0.000000 1,600,000 28 Jun 2024 Common Stock 1,600,000 $5.00 Direct F1, F2
transaction ELTX Pre-Funded Warrants Purchase $7,984,000 +1,600,000 $4.99 1,600,000 28 Jun 2024 Common Stock 1,600,000 $0.0100 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.
F2 The Common Warrants expire on July 1, 2029.
F3 Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.
F4 The Pre-Funded Warrants do not have an expiration date.